BullFrog Data Networks™ extend the bfLEAP™ platform to create purpose-built comprehensive data networks from multimodal data to identify hidden insights. Networks can be created using clinical trial data, EMR, claims, “-omics” data, and all types of real-world data (RWD) — analyzed together using unsupervised machine learning (ML)

Flexible Design: Custom and Partnered Data Sources

The BullFrog Data Networks™ solution is a fully adaptable offering with the capability to incorporate custom data sources from your proprietary preclinical, clinical trials, registry, or market data, as well as data licensed from third party data providers. Contact us to learn more about how we can apply the power of BullFrog Data Networks™ to your data.

Oncology Focus:

The first product offering through BullFrog Data Networks™ leverages a leading cancer genomics data set with over 20,000 primary cancer and matched normal samples including genomic, epigenomic, transcriptomic, and proteomic data. BullFrog Data Networks™ aim to allow stakeholders to derive novel insights toward target identification and validation, understanding mechanism of action, clinical trial optimization, drug repurposing, and more. BullFrog Data Networks™ outputs from the following indications are available (please contact us for additional information):

  • Acute myeloid leukemia
  • Adrenocortical carcinoma
  • Bladder urothelial carcinoma
  • Breast ductal carcinoma
  • Breast lobular carcinoma
  • Cervical carcinoma
  • Cholangiocarcinoma
  • Colorectal adenocarcinoma
  • Esophageal carcinoma
  • Gastric adenocarcinoma
  • Glioblastoma multiforme
  • Head and neck squamous cell carcinoma
  • Hepatocellular carcinoma
  • Chromophobe renal cell carcinoma
  • Clear cell renal cell carcinoma
  • Papillary renal cell carcinoma
  • Lower grade glioma
  • Lung adenocarcinoma
  • Lung squamous cell carcinoma
  • Mesothelioma
  • Ovarian serous adenocarcinoma
  • Pancreatic ductal adenocarcinoma
  • Paraganglioma & pheochromocytoma
  • Prostate adenocarcinoma
  • Sarcoma
  • Skin cutaneous melanoma
  • Testicular germ cell cancer
  • Thymoma
  • Thyroid papillary carcinoma
  • Uterine carcinosarcoma
  • Uterine corpus endometrioid carcinoma
  • Uveal melanoma